Literature DB >> 31049880

Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.

Alessandra T Peana1, Valentina Bassareo2, Elio Acquas3.   

Abstract

The 1,2,3,4-tetrahydroisoquinolines (TIQs) are compounds frequently described as alkaloids that can be found in the human body fluids and/or tissues including the brain. In most circumstances, TIQs may be originated as a consequence of reactions, known as Pictet-Spengler condensations, between biogenic amines and electrophilic carbonyl compounds, including ethanol's main metabolite, acetaldehyde. Several TIQs may also be synthesized enzymatically whilst others may be formed in the body as by-products of other compounds including TIQs themselves. The biological actions of TIQs appear critically dependent on their metabolism, and nowadays, among TIQs, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol), N-methyl-1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (N-methyl-(R)-salsolinol), 1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol (norlaudanosoline or tetrahydropapaveroline or THP) and 1-benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ) are considered as those endowed with the most potent neurotoxic actions. However, it remains to be established whether a continuous exposure to TIQs or to their metabolites might carry toxicological consequences in the short- or long-term period. Remarkably, recent findings suggest that some TIQs such as (1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol) (higenamine) and 1-methyl-1,2,3,4-tetrahydroisoquinoline (1-MeTIQ) as well as N-methyl-tetrahydroisoquinoline (N-methyl-TIQ) exert unique neuroprotective and neurorestorative actions. The present review article provides an overview on these aspects of TIQs and summarizes those that presently appear the most significant highlights on this puzzling topic.

Entities:  

Keywords:  Ethanol; Neuroprotection; Neurotoxicity; Tetrahydroisoquinolines

Mesh:

Substances:

Year:  2019        PMID: 31049880     DOI: 10.1007/s12640-019-00051-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  132 in total

1.  Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes.

Authors:  N Morikawa; M Naoi; W Maruyama; S Ohta; Y Kotake; H Kawai; T Niwa; P Dostert; Y Mizuno
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

2.  Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.

Authors:  Bingjie Xie; Fankai Lin; Lei Peng; Kaleem Ullah; Hanyan Wu; Hong Qing; Yulin Deng
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-10-01       Impact factor: 3.848

3.  1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study.

Authors:  Yaru Song; Yangzheng Feng; Michael H Leblanc; Neal Castagloni; Yi-Ming Liu
Journal:  Neurosci Lett       Date:  2005-11-10       Impact factor: 3.046

4.  Potential roles of NF-kappaB and ERK1/2 in cytoprotection against oxidative cell death induced by tetrahydropapaveroline.

Authors:  Mi-Hyun Shin; Jung-Hee Jang; Young-Joon Surh
Journal:  Free Radic Biol Med       Date:  2004-05-01       Impact factor: 7.376

5.  A critical evaluation of influence of ethanol and diet on salsolinol enantiomers in humans and rats.

Authors:  Jeongrim Lee; Vijay A Ramchandani; Kei Hamazaki; Eric A Engleman; William J McBride; Ting-Kai Li; Hee-Yong Kim
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

6.  Enantiomers of higenamine inhibit LPS-induced iNOS in a macrophage cell line and improve the survival of mice with experimental endotoxemia.

Authors:  Jee Eun Park; Young Jin Kang; Min Kyu Park; Young Soo Lee; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Yun-Choi Hye Sook; Jae Soo Shin; Hong Woo Lee; Soon Kil Ahn; Ki Churl Chang
Journal:  Int Immunopharmacol       Date:  2005-09-12       Impact factor: 4.932

Review 7.  Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.

Authors:  Lucyna Antkiewicz-Michaluk
Journal:  Pol J Pharmacol       Date:  2002 Nov-Dec

Review 8.  Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

Authors:  K S McNaught; P A Carrupt; C Altomare; S Cellamare; A Carotti; B Testa; P Jenner; C D Marsden
Journal:  Biochem Pharmacol       Date:  1998-10-15       Impact factor: 5.858

Review 9.  Free radicals and their scavengers in Parkinson's disease.

Authors:  T Yoshikawa
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

10.  Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Lucyna Antkiewicz-Michaluk
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

View more
  4 in total

Review 1.  The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease.

Authors:  Zixuan Chen; Madiha Rasheed; Yulin Deng
Journal:  Brain Pathol       Date:  2021-08-20       Impact factor: 7.611

2.  Salsolinol-neurotoxic or Neuroprotective?

Authors:  Magdalena Kurnik-Łucka; Gniewomir Latacz; Adrian Martyniak; Andrzej Bugajski; Katarzyna Kieć-Kononowicz; Krzysztof Gil
Journal:  Neurotox Res       Date:  2019-11-15       Impact factor: 3.911

3.  Characterization of Ikaria Heather Honey by Untargeted Ultrahigh-Performance Liquid Chromatography-High Resolution Mass Spectrometry Metabolomics and Melissopalynological Analysis.

Authors:  Konstantinos M Kasiotis; Eirini Baira; Styliani Iosifidou; Kyriaki Bergele; Electra Manea-Karga; Ioannis Theologidis; Theodora Barmpouni; Despina Tsipi; Kyriaki Machera
Journal:  Front Chem       Date:  2022-07-22       Impact factor: 5.545

4.  An essay on the nominal vs. real definitions of aging.

Authors:  Aleksei G Golubev
Journal:  Biogerontology       Date:  2021-06-06       Impact factor: 4.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.